Seek truth from facts, competitive symbiosis
Zhengqing Fengtongning Shines at the Hangzhou Nephrology Academic Conference
Category:
Release time:
2025-12-03
From November 26 to 29, the 2025 Academic Annual Conference of the Nephrology Professional Committee of the Chinese Society of Integrated Traditional and Western Medicine was grandly held in Hangzhou. Centered on the theme of “Balancing Traditional Chinese and Western Medicine, Combining Inheritance with Innovation,” the conference brought together top experts and scholars from across the country in the field of nephrology to discuss cutting-edge developments and breakthroughs in diagnosis and treatment.
As one of the highlights of this grand event, Professor Liu Xusheng, Director of the Nephrology Department at Guangdong Provincial Hospital of Traditional Chinese Medicine, specifically recommended the therapeutic value of Zhengqing Fengtongning in the treatment of kidney diseases during the keynote speech session. His professional endorsement sparked an enthusiastic response from the audience, with numerous experts and scholars taking photos, exchanging ideas, and learning from each other—providing authoritative validation of the product’s strength.
During the annual meeting, the “Zhengqing Fengtongning 50-Person Forum” was successfully held. Wang Xianping, General Manager of the Marketing Center, led the preparation team and invited numerous renowned experts in nephrology from top-tier Grade III hospitals to gather together and discuss... Zhengqing Fengtongning A deep-dive discussion was held on the application of Zhengqing Fengtongning in the diagnosis and treatment of kidney diseases. At the forum, the product manager systematically introduced the clinical application achievements of Zhengqing Fengtongning in the field of kidney diseases, laying a solid foundation for expert exchanges. Professor Jian Guihua from the Sixth People’s Hospital of Shanghai, drawing on her extensive clinical experience, shared practical insights into the real-world use of Zhengqing Fengtongning, particularly offering valuable clinical guidance on optimizing dosage and administration. Professor Liu Xusheng also presented his team’s latest research findings, providing an in-depth analysis of the mechanism of action of Zhengqing Fengtongning in the treatment of kidney diseases and sharing professional advice on managing common adverse reactions encountered in clinical practice. After thorough discussions, the attending experts unanimously praised Zhengqing Fengtongning’s remarkable performance in improving core efficacy indicators such as urinary protein and hematuria, thereby establishing a robust academic foundation for further promoting the product in the field of kidney diseases.
Meanwhile, the company’s meticulously designed booth became a major highlight of the event. Attending experts and scholars learned about it. The package insert for Zhengqing Fengtongning includes chronic nephritis as an indication. Afterward, attendees eagerly stopped by the booth to study product manuals, ask about detailed clinical applications related to indications, and learn about important medication guidelines. To help experts gain a deeper understanding of the product, the booth specially arranged a targeted Q&A interactive session. Through this engaging interaction, participants further reinforced their knowledge of the product’s indications and core values, enhancing Zhengqing Fengtongning’s brand visibility in the field of nephrology and successfully establishing a communication bridge between the product and frontline clinicians.
At this year’s academic conference, Zhengqing Fengtongning was comprehensively showcased through multiple dimensions—including authoritative recommendations by the conference organizers, discussions at specialized forums, and interactive activities at distinctive exhibition booths—demonstrating its clinical value and academic potential in the treatment of kidney diseases and taking the brand’s promotion in the field of nephrology to a new level. Moving forward, our group will continue to deepen our commitment to academic empowerment, leveraging an increasing number of clinical studies and academic exchanges to continually unlock the full potential of our products. In doing so, we aim to bring greater benefits to more patients suffering from kidney diseases and contribute even more significantly to the high-quality development of integrated Chinese and Western medicine approaches to kidney disease prevention and treatment.
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地